Dr. Raghothama Chaerkady is a highly accomplished expert in biochemistry, proteomics and known for his exceptional academic achievements. He earned a Ph.D. degree in Biochemistry in 1999 and later pursued a post-doctoral training program at the prestigious Johns Hopkins University School of Medicine. During his time there, he had the privilege of working in the renowned laboratory of Dr. Akhilesh Pandey, further enhancing his knowledge and skills. One of his most noteworthy achievements was the publication of the ground-breaking paper titled “A Draft Map of the Human Proteome” in Nature in 2014. This seminal work reshaped the landscape of proteomics research especially for biomarker discovery.

Dr. Chaerkady is a distinguished specialist in nanoflow liquid chromatography tandem mass spectrometry-based proteomics assays, coupled with exploratory and targeted quantitative profiling. His prowess extends to performing post-translational modification analysis to decode signaling pathways, targeted and untargeted profiling of biomarkers, and orchestrating immuno-enrichment methods for mass spectrometry assays. Beyond his empirical laboratory capabilities, he possesses a unique knack for assisting bioinformatics teams, aiding in the development of efficient data processing, integration, and visualization pipelines.

His formidable academic portfolio includes over a hundred peer-reviewed research publications, amassing more than 12,000 citations with an impressive h-index of 49. Such scholarly prowess solidifies his standing as a respected and recognized leader in the proteomics field.

Leaving the halls of academia for the fast-paced world of industry, Dr. Chaerkady became an integral part of AstraZeneca in 2015. His tenure in this global pharmaceutical titan has seen him masterfully supervising multiomics application in a myriad of drug discovery and validation projects, honing his team management skills and cultivating productive collaborations across various departments within the organization.

Embodying a harmonious blend of academic expertise and industry experience, Dr. Chaerkady has joined Complete Omics as our esteemed Vice President for proteomics. In this pivotal role, he will spearhead our Research and Development for clinical proteomics assays, while also supervising our proteomics service branch. His guidance and leadership will undoubtedly fortify our preeminent position as a service provider to our extensive clientele, consisting of research institutions and industrial partners alike. We anticipate his significant contributions will further cement our status as leaders in the proteomics sector.